Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)

Group 1 - Johnson & Johnson is participating in the Guggenheim Global Healthcare Conference, focusing on oncology advancements [1][2] - The discussion will primarily cover three main areas: lung cancer, bladder cancer, and multiple myeloma [3] - There is a perceived disconnect between Johnson & Johnson's view of opportunities in lung cancer and the market's current perception [3] Group 2 - The company is making significant progress in bladder cancer treatments, which will also be addressed during the conference [3] - Johnson & Johnson holds a dominant position in the myeloma treatment space and is taking steps to enhance its offerings [3]